We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $1.94B
1-Year Est. Return 20.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+20.77%
3 Year Est. Return
+69.82%
5 Year Est. Return
+88.03%
10 Year Est. Return
+482.02%
AUM
$1.7B
AUM Growth
+$127M
Cap. Flow
-$195M
Cap. Flow %
-11.44%
Top 10 Hldgs %
33.14%
Holding
208
New
16
Increased
24
Reduced
75
Closed
18

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$8.75M
2
ADBE icon
Adobe
ADBE
+$7.75M
3
DUOL icon
Duolingo
DUOL
+$7.16M
4
SKX
Skechers
SKX
+$7.16M
5
FOLD
Amicus Therapeutics
FOLD
+$6.19M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$16.8M
2
MSFT icon
Microsoft
MSFT
+$9.45M
3
AME icon
Ametek
AME
+$8.24M
4
PODD icon
Insulet
PODD
+$7.79M
5
RBC icon
RBC Bearings
RBC
+$7.76M

Sector Composition

Rank Sector Weight
1 Technology 23.97%
2 Healthcare 16.08%
3 Industrials 11.11%
4 Consumer Discretionary 8.24%
5 Consumer Staples 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
76
IBM
IBM
$224B
$1.93M 0.11%
10,130
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.58M 0.09%
3,746
CATX icon
78
Perspective Therapeutics
CATX
$342M
$1.48M 0.09%
124,493
-33,717
-21% -$288K
HD icon
79
Home Depot
HD
$355B
$1.25M 0.07%
3,260
NVDA icon
80
NVIDIA
NVDA
$5.42T
$1.25M 0.07%
13,840
-4,840
-26% -$351K
XOM icon
81
ExxonMobil
XOM
$634B
$1.23M 0.07%
10,577
-265
-2% -$27.7K
JNJ icon
82
Johnson & Johnson
JNJ
$625B
$1.18M 0.07%
7,467
-2,962
-28% -$471K
ESS icon
83
Essex Property Trust
ESS
$18.5B
$993K 0.06%
4,055
ABBV icon
84
AbbVie
ABBV
$435B
$887K 0.05%
4,871
-45
-0.9% -$7.75K
CRM icon
85
Salesforce
CRM
$158B
$842K 0.05%
2,795
-103
-4% -$29.7K
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$4.33T
$727K 0.04%
4,817
-253
-5% -$36.2K
TKNO icon
87
Alpha Teknova
TKNO
$347M
$716K 0.04%
+270,270
New +$839K
XLK icon
88
State Street Technology Select Sector SPDR ETF
XLK
$123B
0
VOO icon
89
Vanguard S&P 500 ETF
VOO
$1.03T
0
COST icon
90
Costco
COST
$420B
$662K 0.04%
903
+137
+18% +$97.8K
MRK icon
91
Merck
MRK
$318B
$634K 0.04%
4,803
-749
-13% -$92.3K
AKYA
92
DELISTED
Akoya BioSciences
AKYA
$592K 0.03%
126,131
PLTR icon
93
Palantir
PLTR
$413B
$561K 0.03%
24,400
-14,600
-37% -$311K
HYS icon
94
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
0
LECO icon
95
Lincoln Electric
LECO
$15.4B
$460K 0.03%
1,800
-400
-18% -$94.5K
ABT icon
96
Abbott
ABT
$187B
$456K 0.03%
4,010
DIS icon
97
Walt Disney
DIS
$181B
$433K 0.03%
3,540
-90
-2% -$9.4K
ISTB icon
98
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
0
VXF icon
99
Vanguard Extended Market ETF
VXF
$31.9B
0
UNH icon
100
UnitedHealth
UNH
$370B
$317K 0.02%
641
-134
-17% -$68.1K

Similar funds

Osterweis Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Osterweis Capital Management held 208 positions worth $1.7B, up 8.1% from $1.58B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Osterweis Capital Management withdrew a net $195M in Q1 2024, closing 18 positions and reducing 75 holdings. Its most notable exit was Insulet, an estimated $7.79M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Osterweis Capital Management opened a new position in Bio-Techne worth $8.61M.

  • Osterweis Capital Management's largest Q1 2024 buy was Bio-Techne: 122,328 shares worth $8.61M.
  • Osterweis Capital Management added most to Adobe in Q1 2024, an estimated $7.75M increase.
  • Osterweis Capital Management's biggest Q1 2024 reduction was Kenvue, cutting an estimated $16.8M.
  • Osterweis Capital Management fully exited Insulet in Q1 2024, selling an estimated $7.79M.
  • Osterweis Capital Management's ten largest holdings make up 33% of its $1.7B portfolio in Q1 2024.
  • Osterweis Capital Management opened 16 new positions and closed 18 in Q1 2024.
  • Osterweis Capital Management's portfolio value rose 8.1% quarter-over-quarter to $1.7B.

Based on Osterweis Capital Management's 13F filing for Q1 2024, filed 15 May 2024.